Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
testosterone undecanoate
|
| gptkbp:approvalYear |
2019
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
G03BA03
|
| gptkbp:chemicalClass |
anabolic steroid
androgen |
| gptkbp:contraindication |
gptkb:cancer
prostate cancer pregnancy |
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jatenzo
|
| gptkbp:indication |
testosterone replacement therapy
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Clarus_Therapeutics
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:scheduleUS |
gptkb:Schedule_III
|
| gptkbp:sideEffect |
gptkb:erythrocytosis
nausea diarrhea headache increased blood pressure |
| gptkbp:usedFor |
male hypogonadism
|
| gptkbp:bfsParent |
gptkb:Clarus_Therapeutics
|
| gptkbp:bfsLayer |
7
|